Search PubMed⌕ Search

Biomedical subjects

C P Bauer

Publications and source records attributed to C P Bauer.

33 records · Page 2Linked to original sources

Determinants of cord-blood IgE concentrations in 6401 German neonates.

For screening atopy risk in 6401 (84%) of all infants born during the year 1990 in six obstetric departments of five German cities, cord-blood IgE values were determined with CAP-RAST-FEIA. After cases with elevated IgA values had been excluded, 25% of the values were above the detection limit of 0.35 kU/l, and 8.5% were above 0.9 kU/l. Boys had significantly higher values than girls (P < 0.001). The distribution of values was significantly different for different nationalities of mothers (P < 0.001). The percentage of elevated values (> 0.9 kU/l) increased significantly with the number of close family members with atopic history (P < 0.001). Regarding the atopic history of the father, siblings, and mother separately, only the mother's history had a significant association with the cord-blood IgE class (P < 0.001). The IgE values of 81 twin pairs correlated significantly with a coefficient of r = 0.4909 (P < 0.001). The smoking history of the parents during pregnancy showed an association with cord-blood IgE values (P < 0.02). No significant association could be shown between cord-blood IgE distribution and other variables, i.e., gestational age, birth size, birth modus, Apgar score, cord-blood pH value, neonatal problems, parity, age of the mother, medication during pregnancy, educational level of mother or father, time of year, or obstetric department. It is hypothesized that, in addition to some postpartum contamination or placental transfer of maternal IgE, cord-blood IgE values are also determined by the fetal immunologic reaction to intrauterine exposure to allergens and trigger factors, and by genetic influences.

Adrenal Cortex Hormones↗

Atopic family history. Validation of instruments in a multicenter cohort study.

In order to identify newborns at risk for atopic diseases, we developed a family questionnaire and selected specific answers which were suitable to identify atopic family members. The validity of the questionnaire was evaluated by the Phadiatop test results of 793 mothers and 353 fathers. As both screening instruments do not measure the same, the Phadiatop test identifies sensitization to inhalant allergens and the history reflects the clinical manifestation of atopic disease, the agreement between sensitization and manifestation is incomplete. Sensitivity and specificity of the questionnaire screening conditions to reproduce the Phadiotop test result was 64% and 84% for mothers, and 58% and 88% for fathers, respectively. The relative risk for lifetime prevalence of atopic manifestations in Phadiatop positive over negative mothers was calculated to be 3.88 (95% confidence interval = 3.12 to 4.81), and for Phadiatop positive over negative fathers to amount 4.84 (95% confidence interval 3.25 to 7.23). A few relevant answers of 20 were identified by logistic regression analysis to predict the Phadiatop test result nearly, as well as the total questionnaire.

Adult↗

[Criteria for determining the degree of handicap in bronchial asthma in childhood].

Patients history, clinical findings, pulmonary function and necessary therapy are combined for a diagram, which should easily allow to grade childhood asthma for general practitioners, pediatricians and consultants of the health insurance. The grading system is based on the cited literature, dealing in part with the matter, and on the international consensus report on asthma.

Asthma↗

[Development of atopic disease in early childhood--predisposing factors].

In this study, we attempted to find factors which predispose infants to atopy. 200 unselected newborns were followed up to 3 years of age. Children with elevated cordblood IgE or positive family history developed atopic disease significantly more frequent (p less than 0.05, p less than 0.01). Parental smoking or formula feeding alone did not influence the frequency of subsequent atopic disorders. However, in combination with reduced cordblood CD8-cells atopy was observed significantly more often (p less than 0.05, p less than 0.025). Similar results were found in children with reduced cordblood CD3-cells, whose parents were smokers (p less than 0.01). These results suggest that factors which alone do not influence atopy can enhance each other to predispose atopic disease in early childhood.

Asthma↗

A placebo-controlled blinded comparison of nedocromil sodium and beclomethasone dipropionate in bronchial asthma.

Two hundred and two patients aged 12-78 with chiefly moderate to severe asthma took part in a multicenter randomized blinded group comparison of nedocromil sodium (NS) 4 mg four times daily, beclomethasone dipropionate (BD) 0.1 mg four times daily, and placebo. Patients were assessed at the start and end of a two week baseline and after three and six weeks of treatment. Compared with placebo, both NS and BD significantly improved daytime dyspnoea and day and nighttime cough, as assessed by diary card scores. Lung function (FEV1) was significantly improved in the BD group. In the NS group there was also a significant reduction in concomitant use of inhaled beta 2-agonists. Overall opinions of efficacy by clinicians and patients were significantly in favor of both active treatments over placebo. There were no significant differences between the three treatments for peak expiratory flow rates, morning tightness or nighttime dyspnoea. Comparison between the two active treatments showed no significant differences in any of the variables.

Adolescent↗

[Nutrition in atopic diseases].

The incidence of food allergy in childhood is estimated with 5-20%. Food allergy can present with diarrhea, exanthems and dermatitis, wheezing bronchitis and as anaphylactic shock. The diagnosis of food allergy is possible with skin-test, RAST etc. and especially by provocation and food elimination. A food allergy, proven by elimination-diet and provocation-diet, can be treated with an individually composed diet. Such diets have to be balanced very exactly to avoid malnutrition.

Child↗

[Radiologic findings and differential diagnosis of bronchial asthma in childhood].

In children with asthma, routine chest X-ray typically shows bilaterally increased air volume, low diaphragms, wide diaphragmatic angles, and often a slender cardiac silhouette with a prominent pulmonic arch. Such an X-ray is not diagnostic of asthma itself, however, but rather of its complications: pneumonitis (particularly in toddlers with infectious asthma), atelectasis due to mucus obstruction, and, rarely, extra-alveolar air trapping (pneumomediastinum with or without cutaneous emphysema more often than pneumothorax). The differential diagnosis has to rule out "pseudo asthma" due to cystic fibrosis, alveolitis, achalasia, and foreign body aspiration.

Adolescent↗

A placebo-controlled, blind comparison of nedocromil sodium and beclomethasone dipropionate in bronchial asthma.

A multi-centre, randomized, blind comparative group study was carried out in 202 adult patients, who had suffered from asthma for at least 2 years, to assess the effectiveness and tolerability of maintenance treatment with either 4 mg nedocromil sodium 4-times daily, 0.1 mg beclomethasone dipropionate 4-times daily or 2 puffs of placebo 4-times daily, given by inhalation. Lung function (FEV1 and sRaw) measurements were made at the beginning and end of a 2-week baseline period and then after 3 and 6 weeks of treatment: assessment were also made of asthma severity. Patients recorded daily on diary cards details of morning and evening PEFR, usage of inhaled bronchodilators, severity of dyspnoea, cough and morning tightness. The results showed that, compared with placebo, both nedocromil sodium and beclomethasone dipropionate-treated patients showed an improvement in FEV1 and a reduction in sRaw values: PEFR increased slightly in all three groups. There was an improvement in asthma severity, diminished rate of dyspnoea and cough, and reduced usage of inhaled bronchodilators in patients receiving active treatment but not in those on placebo. Overall assessment of treatment efficacy by both investigators and patients showed that opinions were significantly in favour of active treatment over placebo. Treatment was well tolerated and no serious side-effects were reported. It was concluded that at the dosages used nedocromil sodium was comparable with and equivalent to inhaled beclomethasone dipropionate in nearly all of the parameters assessed, and both drugs were superior to placebo in the maintenance treatment of asthma in adult patients.

Adolescent↗

[Effect of nedocromil sodium on the hyperreactivity of the bronchial system in young asthmatic patients].

The protective effect of nedocromil sodium on asthmatic children was investigated by exercise provocation test in a placebo-controlled, double-blind, randomized crossover trial. Lung function impairment during exercise was significantly less (p less than 0.05) with nedocromil sodium than with placebo. The maximum impairment of lung function after exercise challenge was significantly less (p less than 0.05) with nedocromil sodium than with placebo. No side-effect were observed.

Adolescent↗

Cord blood T-cell determination: a further useful parameter for atopy screening of the newborn?

In a prospective study, the total CB IgE and T-cell subpopulations in cord blood of 200 newborn children were determined by means of monoclonal antibodies (CD3, CD4, and CD8). There is no correlation between raised cord blood IgE and reduced T-cell ratio in the cord blood or with a positive family history. In a follow-up study carried out at the age of 12 to 14 months, 21% of atopic children had a positive family history and, simultaneously, a reduced total cord blood T-cell rate (CD3). Only 3% of nonatopic children had a positive family history and a reduced cord blood CD3 ratio. Statistically speaking, this distinction is significant (p less than 0.01).

Female↗